Skip to main content
Journal cover image

Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.

Publication ,  Journal Article
Jahan, R; Saver, JL; Schwamm, LH; Fonarow, GC; Liang, L; Matsouaka, RA; Xian, Y; Holmes, DN; Peterson, ED; Yavagal, D; Smith, EE
Published in: JAMA
July 16, 2019

IMPORTANCE: Randomized clinical trials suggest benefit of endovascular-reperfusion therapy for large vessel occlusion in acute ischemic stroke (AIS) is time dependent, but the extent to which it influences outcome and generalizability to routine clinical practice remains uncertain. OBJECTIVE: To characterize the association of speed of treatment with outcome among patients with AIS undergoing endovascular-reperfusion therapy. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study using data prospectively collected from January 2015 to December 2016 in the Get With The Guidelines-Stroke nationwide US quality registry, with final follow-up through April 15, 2017. Participants were 6756 patients with anterior circulation large vessel occlusion AIS treated with endovascular-reperfusion therapy with onset-to-puncture time of 8 hours or less. EXPOSURES: Onset (last-known well time) to arterial puncture, and hospital arrival to arterial puncture (door-to-puncture time). MAIN OUTCOMES AND MEASURES: Substantial reperfusion (modified Thrombolysis in Cerebral Infarction score 2b-3), ambulatory status, global disability (modified Rankin Scale [mRS]) and destination at discharge, symptomatic intracranial hemorrhage (sICH), and in-hospital mortality/hospice discharge. RESULTS: Among 6756 patients, the mean (SD) age was 69.5 (14.8) years, 51.2% (3460/6756) were women, and median pretreatment score on the National Institutes of Health Stroke Scale was 17 (IQR, 12-22). Median onset-to-puncture time was 230 minutes (IQR, 170-305) and median door-to-puncture time was 87 minutes (IQR, 62-116), with substantial reperfusion in 85.9% (5433/6324) of patients. Adverse events were sICH in 6.7% (449/6693) of patients and in-hospital mortality/hospice discharge in 19.6% (1326/6756) of patients. At discharge, 36.9% (2132/5783) ambulated independently and 23.0% (1225/5334) had functional independence (mRS 0-2). In onset-to-puncture adjusted analysis, time-outcome relationships were nonlinear with steeper slopes between 30 to 270 minutes than 271 to 480 minutes. In the 30- to 270-minute time frame, faster onset to puncture in 15-minute increments was associated with higher likelihood of achieving independent ambulation at discharge (absolute increase, 1.14% [95% CI, 0.75%-1.53%]), lower in-hospital mortality/hospice discharge (absolute decrease, -0.77% [95% CI, -1.07% to -0.47%]), and lower risk of sICH (absolute decrease, -0.22% [95% CI, -0.40% to -0.03%]). Faster door-to-puncture times were similarly associated with improved outcomes, including in the 30- to 120-minute window, higher likelihood of achieving discharge to home (absolute increase, 2.13% [95% CI, 0.81%-3.44%]) and lower in-hospital mortality/hospice discharge (absolute decrease, -1.48% [95% CI, -2.60% to -0.36%]) for each 15-minute increment. CONCLUSIONS AND RELEVANCE: Among patients with AIS due to large vessel occlusion treated in routine clinical practice, shorter time to endovascular-reperfusion therapy was significantly associated with better outcomes. These findings support efforts to reduce time to hospital and endovascular treatment in patients with stroke.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

July 16, 2019

Volume

322

Issue

3

Start / End Page

252 / 263

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Time-to-Treatment
  • Stroke
  • Retrospective Studies
  • Reperfusion
  • Registries
  • Middle Aged
  • Mechanical Thrombolysis
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jahan, R., Saver, J. L., Schwamm, L. H., Fonarow, G. C., Liang, L., Matsouaka, R. A., … Smith, E. E. (2019). Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. JAMA, 322(3), 252–263. https://doi.org/10.1001/jama.2019.8286
Jahan, Reza, Jeffrey L. Saver, Lee H. Schwamm, Gregg C. Fonarow, Li Liang, Roland A. Matsouaka, Ying Xian, et al. “Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.JAMA 322, no. 3 (July 16, 2019): 252–63. https://doi.org/10.1001/jama.2019.8286.
Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, et al. Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. JAMA. 2019 Jul 16;322(3):252–63.
Jahan, Reza, et al. “Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.JAMA, vol. 322, no. 3, July 2019, pp. 252–63. Pubmed, doi:10.1001/jama.2019.8286.
Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, Xian Y, Holmes DN, Peterson ED, Yavagal D, Smith EE. Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. JAMA. 2019 Jul 16;322(3):252–263.
Journal cover image

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

July 16, 2019

Volume

322

Issue

3

Start / End Page

252 / 263

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Time-to-Treatment
  • Stroke
  • Retrospective Studies
  • Reperfusion
  • Registries
  • Middle Aged
  • Mechanical Thrombolysis
  • Male